Bausch Health Companies Inc BHC-CA:Toronto Stock Exchange

*Data is delayed | CAD
Last | 02/26/21 EST
40.05quote price arrow up+0.62 (+1.57%)
Volume
1,204,794
52 week range
16.30 - 41.38

...

Loading . . .

KEY STATS

  • Open39.72
  • Day High40.54
  • Day Low38.85
  • Prev Close39.43
  • 52 Week High41.38
  • 52 Week High Date02/17/21
  • 52 Week Low16.30
  • 52 Week Low Date03/18/20
  • Market Cap11,446.81M
  • Shares Out355.42M
  • 10 Day Average Volume722,191.91
  • Dividend-
  • Dividend Yield-
  • Beta1.62
  • 1 Year % Change23

RATIOS/PROFITABILITY

  • EPS (TTM)-2.01
  • P/E (TTM)-19.92
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date05/17/2007
  • Div Amount0.375
  • Split Date-
  • Split Factor-

QUOTE FINDER

Profile

MORE
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other...
Joseph Papa
Chairman
Paul Herendeen
Chief Financial Officer
Christina Ackermann
Executive Vice President
Address
2150 Saint-Elzear Blvd W
Laval, QC
H7L 4A8
Canada